Digital signature standards group lowers fees

SAFE-BioPharma Association, the drug industry group that champions standards for verifying digital identities, has changed its fee structure. "We are systematically bringing down the cost," CEO Mollie Shields-Uehling said during an interview with FierceBiotech IT at DIA. For companies with 2,000 or fewer employees, the fee is now $50 per year per digital signer.

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.